NCT00002369

Brief Summary

To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.

Trial Health

85
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable hiv-infections

Geographic Reach
2 countries

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 1999

Completed
1.8 years until next milestone

First Posted

Study publicly available on registry

August 31, 2001

Completed
Last Updated

October 2, 2007

Status Verified

October 1, 2007

First QC Date

November 2, 1999

Last Update Submit

October 1, 2007

Conditions

Keywords

Drug Therapy, CombinationZidovudineStavudineHIV Protease InhibitorsCD4 Lymphocyte CountLamivudineIndinavirReverse Transcriptase InhibitorsAnti-HIV AgentsViral Load

Interventions

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have:
  • Documented HIV infection.
  • CD4 cell count of 200 - 700 cells/mm3.

You may not qualify if:

  • Co-existing Condition:
  • Patients with the following symptoms or conditions are excluded:
  • AIDS defining condition within 1 month of study entry.
  • Prior Medication:
  • Excluded:
  • Patients with any history of antiretroviral therapy treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Univ of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

HIV Clinical Research Ctr

Fort Lauderdale, Florida, 33316, United States

Location

Infectious Disease Research Institute Inc

Tampa, Florida, 33614, United States

Location

Advance Clinical Research

Atlanta, Georgia, 30327, United States

Location

Louisiana State Univ Med Ctr / HIV Outpatient Clinic

New Orleans, Louisiana, 70112, United States

Location

Boston Univ Med Ctr Hosp / Evans - 556

Boston, Massachusetts, 02118, United States

Location

Community Research Initiative of New England

Brookline, Massachusetts, 02445, United States

Location

Washington Univ School of Medicine

St Louis, Missouri, 63108, United States

Location

Blackstock Family Health Ctr

Austin, Texas, 76751, United States

Location

Hosp Regional de Ponce - Area Vieja

Ponce, 00731, Puerto Rico

Location

San Juan AIDS Program

Santurce, 00908, Puerto Rico

Location

MeSH Terms

Conditions

HIV Infections

Interventions

IndinavirLamivudineStavudineZidovudine

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

PyridinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsZalcitabineDeoxycytidineCytidinePyrimidine NucleosidesPyrimidinesDeoxyribonucleosidesNucleosidesNucleic Acids, Nucleotides, and NucleosidesDideoxynucleosidesThymidine

Study Design

Study Type
interventional
Phase
not applicable
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 2, 1999

First Posted

August 31, 2001

Last Updated

October 2, 2007

Record last verified: 2007-10

Locations